← Open Payments lookup

JULIANA AMUZU-DOE: Open Payments

NPI 1245901388 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,745 in 78 payments from 14 companies in 2025. Trend: 2023 $1,208 · 2024 $1,172 · 2025 $1,745

Food & beverage: $1,745
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$466
Otsuka America Pharmaceutical, Inc.13$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$209
E.R. Squibb & Sons, L.L.C.10$187
Teva Pharmaceuticals USA, Inc.11$151
Axsome Therapeutics, Inc.6$143
Gilead Sciences, Inc.1$92
MIMEDX Group, Inc.1$91
Collegium Pharmaceutical, Inc.2$43
Tris Pharma Inc2$34

Products named: INGREZZA, REXULTI, CAPLYTA, COBENFY, Auvelity, UZEDY, Livdelzi, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.